Teledyne to Acquire Varex Imaging in $1.1 Billion Deal Today
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
MORGES, Switzerland, July 20, 2026 Spectrum Dynamics Medical has announced the launch of the All-Energy Enhancement for its FDA-cleared,...
Melbourne, Australia and Indianapolis, IN, United States – May 5, 2026 Telix Pharmaceuticals Limited has announced the publication of...
ATLANTA, Georgia, USA, April 28, 2026 PharmaLogic Holdings Corp., a leading contract development and manufacturing organization (CDMO) specializing in...
Amsterdam, Netherlands – April 22, 2026 In a significant advancement for medical imaging technology, Philips has received U.S. FDA...
SYDNEY, April 16, 2026 Radiopharmaceutical innovation continues to reshape oncology diagnostics as Radiopharm Theranostics announced completion of enrollment in...
Sydney, Australia | April 14, 2026 Clarity Pharmaceuticals has announced the signing of a Commercial Manufacturing Agreement with Nucleus...
